Molecular profiling of long‐term responders to immune checkpoint inhibitors in advanced non‐small cell lung cancer

Molecular profiling of long‐term responders to immune checkpoint inhibitors in advanced non‐small cell lung cancer

Immunotherapy has transformed advanced non‐small cell lung cancer (NSCLC) treatment strategies and has led to unprecedented long‐lasting responses in some patients. However, the molecular determinants driving these long‐term responses remain elusive. To address this issue, we performed an integrativ...

Full description

Bibliographic Details
Main Authors: Joan Frigola, Alejandro Navarro, Caterina Carbonell, Ana Callejo, Patricia Iranzo, Susana Cedrés, Alex Martinez‐Marti, Nuria Pardo, Nadia Saoudi‐Gonzalez, Debora Martinez, Jose Jimenez, Irene Sansano, Francesco M. Mancuso, Paolo Nuciforo, Luis M. Montuenga, Montse Sánchez‐Cespedes, Aleix Prat, Ana Vivancos, Enriqueta Felip, Ramon Amat
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:Molecular Oncology
Subjects:
chromosomal alterations burden
copy number alterations
immune checkpoint inhibitors
long‐term benefit
NSCLC
PD‐L1
Online Access:https://doi.org/10.1002/1878-0261.12891

Internet

https://doi.org/10.1002/1878-0261.12891

Similar Items